187 related articles for article (PubMed ID: 9151894)
21. Cell lines transfected with the TAP inhibitor ICP47 allow testing peptide binding to a variety of HLA class I molecules.
Gatfield J; Lammert E; Nickolaus P; Münz C; Rothenfusser S; Fisch P; Stevanović S; Schild H; Rammensee HG; Arnold D
Int Immunol; 1998 Nov; 10(11):1665-72. PubMed ID: 9846695
[TBL] [Abstract][Full Text] [Related]
22. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
[TBL] [Abstract][Full Text] [Related]
23. Functional cysteine-less subunits of the transporter associated with antigen processing (TAP1 and TAP2) by de novo gene assembly.
Heintke S; Chen M; Ritz U; Lankat-Buttgereit B; Koch J; Abele R; Seliger B; Tampé R
FEBS Lett; 2003 Jan; 533(1-3):42-6. PubMed ID: 12505156
[TBL] [Abstract][Full Text] [Related]
24. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.
Ahn K; Gruhler A; Galocha B; Jones TR; Wiertz EJ; Ploegh HL; Peterson PA; Yang Y; Früh K
Immunity; 1997 May; 6(5):613-21. PubMed ID: 9175839
[TBL] [Abstract][Full Text] [Related]
25. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
Li S; Paulsson KM; Sjögren HO; Wang P
J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102
[TBL] [Abstract][Full Text] [Related]
26. The varicellovirus UL49.5 protein blocks the transporter associated with antigen processing (TAP) by inhibiting essential conformational transitions in the 6+6 transmembrane TAP core complex.
Verweij MC; Koppers-Lalic D; Loch S; Klauschies F; de la Salle H; Quinten E; Lehner PJ; Mulder A; Knittler MR; Tampé R; Koch J; Ressing ME; Wiertz EJ
J Immunol; 2008 Oct; 181(7):4894-907. PubMed ID: 18802093
[TBL] [Abstract][Full Text] [Related]
27. Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8
Abdulhaqq SA; Wu H; Schell JB; Hammond KB; Reed JS; Legasse AW; Axthelm MK; Park BS; Asokan A; Früh K; Hansen SG; Picker LJ; Sacha JB
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315990
[TBL] [Abstract][Full Text] [Related]
28. A dual inhibition mechanism of herpesviral ICP47 arresting a conformationally thermostable TAP complex.
Herbring V; Bäucker A; Trowitzsch S; Tampé R
Sci Rep; 2016 Nov; 6():36907. PubMed ID: 27845362
[TBL] [Abstract][Full Text] [Related]
29. Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses.
Momburg F; Hengel H
Curr Top Microbiol Immunol; 2002; 269():57-74. PubMed ID: 12224516
[TBL] [Abstract][Full Text] [Related]
30. Structure and dynamics of membrane-associated ICP47, a viral inhibitor of the MHC I antigen-processing machinery.
Aisenbrey C; Sizun C; Koch J; Herget M; Abele R; Bechinger B; Tampé R
J Biol Chem; 2006 Oct; 281(41):30365-72. PubMed ID: 16835230
[TBL] [Abstract][Full Text] [Related]
31. ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice.
Burgos JS; Serrano-Saiz E; Sastre I; Valdivieso F
J Neurovirol; 2006 Dec; 12(6):420-7. PubMed ID: 17162658
[TBL] [Abstract][Full Text] [Related]
32. Nucleotide binding to the hydrophilic C-terminal domain of the transporter associated with antigen processing (TAP).
Müller KM; Ebensperger C; Tampé R
J Biol Chem; 1994 May; 269(19):14032-7. PubMed ID: 8188683
[TBL] [Abstract][Full Text] [Related]
33. Head-head/tail-tail relative orientation of the pore-forming domains of the heterodimeric ABC transporter TAP.
Vos JC; Reits EA; Wojcik-Jacobs E; Neefjes J
Curr Biol; 2000 Jan; 10(1):1-7. PubMed ID: 10660295
[TBL] [Abstract][Full Text] [Related]
34. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.
York IA; Roop C; Andrews DW; Riddell SR; Graham FL; Johnson DC
Cell; 1994 May; 77(4):525-35. PubMed ID: 8187174
[TBL] [Abstract][Full Text] [Related]
35. Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits.
Antoniou AN; Ford S; Pilley ES; Blake N; Powis SJ
Immunology; 2002 Jun; 106(2):182-9. PubMed ID: 12047747
[TBL] [Abstract][Full Text] [Related]
36. Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing.
Halenius A; Momburg F; Reinhard H; Bauer D; Lobigs M; Hengel H
J Biol Chem; 2006 Mar; 281(9):5383-90. PubMed ID: 16356928
[TBL] [Abstract][Full Text] [Related]
37. Impaired transporter associated with antigen processing (TAP) function attributable to a single amino acid alteration in the peptide TAP subunit TAP1.
Ritz U; Drexler I; Sutter D; Abele R; Huber C; Seliger B
J Immunol; 2003 Jan; 170(2):941-6. PubMed ID: 12517960
[TBL] [Abstract][Full Text] [Related]
38. Structure of the transporter associated with antigen processing trapped by herpes simplex virus.
Oldham ML; Grigorieff N; Chen J
Elife; 2016 Dec; 5():. PubMed ID: 27935481
[TBL] [Abstract][Full Text] [Related]
39. The influence of TAP1 and TAP2 gene polymorphisms on TAP function and its inhibition by viral immune evasion proteins.
Praest P; Luteijn RD; Brak-Boer IGJ; Lanfermeijer J; Hoelen H; Ijgosse L; Costa AI; Gorham RD; Lebbink RJ; Wiertz EJHJ
Mol Immunol; 2018 Sep; 101():55-64. PubMed ID: 29879547
[TBL] [Abstract][Full Text] [Related]
40. Catalytic site modifications of TAP1 and TAP2 and their functional consequences.
Perria CL; Rajamanickam V; Lapinski PE; Raghavan M
J Biol Chem; 2006 Dec; 281(52):39839-51. PubMed ID: 17068338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
